Am I reading this right or is Domacom proposing up to another 25% of potentially discounted new shares be available to be issued after the upcoming AGM. Lets not forget that 9.5 million shares that were issued at a 20+% discount to market on the 4th September 2018. Is the calculation ( approx) 10% +15% + 10% = 35% plus the Lind Transaction and other Board and Executive Performance Bonuses. Has anyone done the sums on the total dilution effect if all the new shares are issued together with the other previous issues in 2018.
......and it seems the criteria of who receives these potentially discounted shares will be left to the Domacom . Does any one know who got the 9.5 million shares in the domacoms private placement on the 4th September 2018.
Resolution 7 at the AGM says in part (Extract):
Resolution 7 – Approval of 10% Placement Capacity Listing Rule 7.1A enables an Eligible Entity to seek approval by special resolution at its Annual General Meeting to issue Equity Securities up to 10% of its issued capital over a period of up to 12 months after the Annual General Meeting, in addition to those under the 15% annual placement capacity ....(10% Placement Capacity). ........
........) Allocation under the 10% Placement Capacity The allottees of the Equity Securities to be issued under the 10% Placement Capacity have not yet been determined. However, the allottees of Equity Securities could consist of current Shareholders or new investors (or both), none of whom will be related parties of the Company. The Company will determine the allottees at the time of the issue under the 10% Placement Capacity, having regard to the following factors: (i) the purpose of the issue; (ii) alternative methods for raising funds available to the Company at that time, including, but not limited to, an entitlement issue or other offer where existing Shareholders may participate; (iii) the effect of the issue of the Equity Securities on the control of the Company; (iv) the circumstances of the Company, including, but not limited to, the financial position and solvency of the Company; (v) prevailing market conditions; and (vi) advice from corporate, financial and braking advisers (if applicable).
- Forums
- ASX - By Stock
- DCL
- More new Shares Proposed at AGM
More new Shares Proposed at AGM
Featured News
Add DCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.790M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DCL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online